Fusion peptides from oncogenic chimeric proteins as putative specific biomarkers of cancer.
about
ALK-driven tumors and targeted therapy: focus on crizotinibProteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic VariationProteogenomics from a bioinformatics angle: A growing field.Proteogenomics for understanding oncology: recent advances and future prospects.Combining bioinformatics and MS-based proteomics: clinical implications.Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
P2860
Fusion peptides from oncogenic chimeric proteins as putative specific biomarkers of cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@en
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@nl
type
label
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@en
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@nl
prefLabel
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@en
Fusion peptides from oncogenic ...... specific biomarkers of cancer.
@nl
P2093
P2860
P50
P356
P1476
Fusion peptides from oncogenic ...... specific biomarkers of cancer
@en
P2093
Delphine Rolland
Kevin P Conlon
Thomas Wolfe
Venkatesha Basrur
P2860
P304
P356
10.1074/MCP.M113.029926
P577
2013-07-08T00:00:00Z